Li L - Search Results

1

Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia.

Wang C, Li L, Li M, Shen X, Liu Y, Wang S. Wang C, et al. Among authors: li m, li l. Exp Cell Res. 2021 Jan 1;398(1):112371. doi: 10.1016/j.yexcr.2020.112371. Epub 2020 Nov 11. Exp Cell Res. 2021. PMID: 33188849

2

Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression.

Wang C, Li L, Li M, Wang W, Liu Y, Wang S. Wang C, et al. Among authors: li m, li l. Mol Med. 2020 Nov 24;26(1):114. doi: 10.1186/s10020-020-00229-4. Mol Med. 2020. PMID: 33228517 Free PMC article.

3

Strongylocentrotus nudos Egg Polysaccharide induces autophagy and apoptosis in leukaemia cells by regulating mitochondrial function.

Wang C, Li M, Li L, Shen X, Liu Y, Wang S. Wang C, et al. Among authors: li m, li l. J Cell Mol Med. 2021 Jan;25(1):272-283. doi: 10.1111/jcmm.15995. Epub 2020 Dec 1. J Cell Mol Med. 2021. PMID: 33289295 Free PMC article.

4

Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371].

Wang C, Li L, Li M, Shen X, Liu Y, Wang S. Wang C, et al. Among authors: li m, li l. Exp Cell Res. 2021 Mar 1;400(1):112469. doi: 10.1016/j.yexcr.2020.112469. Epub 2021 Jan 9. Exp Cell Res. 2021. PMID: 33431171 No abstract available.

5

Case Report: 7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth.

Wang A, Li L, Li M, Wang S, Wang C. Wang A, et al. Among authors: li m, li l. Front Pharmacol. 2021 Apr 29;12:664176. doi: 10.3389/fphar.2021.664176. eCollection 2021. Front Pharmacol. 2021. PMID: 33995089 Free PMC article.

6

Corrigendum: 7-Ethyl-10-Hydroxycamptothecin, A DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth.

Wang A, Li L, Li M, Wang S, Wang C. Wang A, et al. Among authors: li m, li l. Front Pharmacol. 2021 Aug 30;12:757060. doi: 10.3389/fphar.2021.757060. eCollection 2021. Front Pharmacol. 2021. PMID: 34526906 Free PMC article.

7

FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma.

Wang C, Li L, Li M, Wang W, Jiang Z. Wang C, et al. Among authors: li m, li l. Cancer Gene Ther. 2023 Apr;30(4):622-628. doi: 10.1038/s41417-022-00429-6. Epub 2022 Feb 10. Cancer Gene Ther. 2023. PMID: 35145273

8

Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.

Wang A, Chen Y, Shi L, Li M, Li L, Wang S, Wang C. Wang A, et al. Among authors: li m, li l. J Transl Med. 2022 Jun 27;20(1):288. doi: 10.1186/s12967-022-03456-x. J Transl Med. 2022. PMID: 35761379 Free PMC article.

9

[Clinical Features and Prognosis of Multiple Myeloma Patients with Secondary Primary Malignancies].

Li LL, Li ML, Zhang Y, Liu Y, Liu YF, Jiang ZX, Chen SQ, Wang SJ, Wang C. Li LL, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Apr;31(2):429-434. doi: 10.19746/j.cnki.issn.1009-2137.2023.02.017. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37096515 Clinical Trial. Chinese.

10

[Development of a Prognostic Model for Overall Survival Adult Patients with Core Binding Factor Acute Myeloid Leukaemia].

Shi LY, Li LL, Li T, Li YF, Liu YF, Jiang ZX, Wang SJ, Wang C. Shi LY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Jun;32(3):693-701. doi: 10.19746/j.cnki.issn.1009-2137.2024.03.007. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38926955 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,483 results

Search Page

Filters